Neotherix Limited
Neotherix is a company dedicated to developing innovative bioresorbable scaffolds for tissue repair, utilizing electrospinning technology to create 3D structures that support the body's natural healing process. Their mission is to address problem wounds, including acute, surgical, infected, and chronic wounds, by harnessing the body's ability to repair itself through advanced regenerative solutions.
Industries
Nr. of Employees
small (1-50)
Neotherix Limited
Neotherix Ltd, Business Club, The Hiscox Building, Peasholme Green, York, YO1 7PR, UK
Patents
Products
Electrospun tissue repair scaffold for acute and surgical wounds
A bioresorbable electrospun scaffold engineered to support cell infiltration and tissue regeneration in acute and surgical wound sites; designed to degrade by hydrolysis during healing.
Theranostic scaffold system for wound monitoring and healing
Combined scaffold and thermally switchable hydrogel system that permits non-destructive collection of wound biomarkers and facilitates tissue repair; designed to support point-of-care biomarker analysis.
Light-activated antimicrobial scaffold for dental and dermal wounds
Scaffold constructs containing photodynamically active fibres that release antimicrobial activity upon light activation to reduce reliance on antibiotics and avoid contribution to antimicrobial resistance.
Bioresorbable seton-scaffold device for fistula tract management
A narrow, resorbable scaffold combined with a drainage seton designed to be placed in fistula tracts to allow simultaneous drainage and scaffold-mediated tissue regrowth, aiming to preserve continence and reduce need for repeated surgeries.
Electrospun tissue repair scaffold for acute and surgical wounds
A bioresorbable electrospun scaffold engineered to support cell infiltration and tissue regeneration in acute and surgical wound sites; designed to degrade by hydrolysis during healing.
Theranostic scaffold system for wound monitoring and healing
Combined scaffold and thermally switchable hydrogel system that permits non-destructive collection of wound biomarkers and facilitates tissue repair; designed to support point-of-care biomarker analysis.
Light-activated antimicrobial scaffold for dental and dermal wounds
Scaffold constructs containing photodynamically active fibres that release antimicrobial activity upon light activation to reduce reliance on antibiotics and avoid contribution to antimicrobial resistance.
Bioresorbable seton-scaffold device for fistula tract management
A narrow, resorbable scaffold combined with a drainage seton designed to be placed in fistula tracts to allow simultaneous drainage and scaffold-mediated tissue regrowth, aiming to preserve continence and reduce need for repeated surgeries.
Services
Management of device design progression through technology readiness levels, coordination with collaborators, subcontractors and stakeholders, and project delivery for clinical translation.
Preparation and assembly of clinical investigation documentation, coordination of First-in-Man and multi-centre trial logistics, and interactions with funders and clinical investigators.
Process planning and oversight for sterile device manufacture and supply to clinical trials, including assembly of device manufacturing documentation.
Formation and management of collaborative projects with academic and clinical partners to secure grant funding and deliver translational research outputs.
Management of device design progression through technology readiness levels, coordination with collaborators, subcontractors and stakeholders, and project delivery for clinical translation.
Preparation and assembly of clinical investigation documentation, coordination of First-in-Man and multi-centre trial logistics, and interactions with funders and clinical investigators.
Process planning and oversight for sterile device manufacture and supply to clinical trials, including assembly of device manufacturing documentation.
Formation and management of collaborative projects with academic and clinical partners to secure grant funding and deliver translational research outputs.
Expertise Areas
- Electrospun biomaterials for tissue regeneration
- Wound theranostics and point-of-care biomarker sampling
- Photodynamic antimicrobial therapy for implants
- Biomaterial surface functionalisation
Key Technologies
- Electrospinning
- Electrospun bioresorbable polymer scaffolds
- Thermally switchable (thermoresponsive) hydrogels
- Photodynamically active fibres / photodynamic therapy
News & Updates
Further funding for Seton-Scaffold device to improve treatment of anal fistula, supporting a clinical study across 10 UK hospitals.
Research at UEA demonstrates RegeniTherix™'s capability to sample wound biomarkers non-invasively.
Welcomes Daisy Redman as Production Technologist to manage device manufacture and development.
Clare will oversee the product portfolio and facilitate progression to commercialization.
UEA researchers published a paper in Bioconjugate Chemistry on rapid immobilization of protein on polyester microcarriers using click chemistry.
Discussion on developing electrospun scaffolds for tissue regeneration and the company's role in the industry.
Further funding for Seton-Scaffold device to improve treatment of anal fistula, supporting a clinical study across 10 UK hospitals.
Research at UEA demonstrates RegeniTherix™'s capability to sample wound biomarkers non-invasively.
Welcomes Daisy Redman as Production Technologist to manage device manufacture and development.
Clare will oversee the product portfolio and facilitate progression to commercialization.
UEA researchers published a paper in Bioconjugate Chemistry on rapid immobilization of protein on polyester microcarriers using click chemistry.
Discussion on developing electrospun scaffolds for tissue regeneration and the company's role in the industry.